In the last trading session, 15.77 million shares of the Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) were traded, and its beta was -0.91. Most recently the company’s share price was $0.18, and it changed around -$0.03 or -13.65% from the last close, which brings the market valuation of the company to $6.47M. COEP currently trades at a discount to its 52-week high of $0.82, offering almost -355.56% off that amount. The share price’s 52-week low was $0.13, which indicates that the current value has risen by an impressive 27.78% since then. We note from Coeptis Therapeutics Holdings Inc’s average daily trading volume that its 10-day average is 22.93 million shares, with the 3-month average coming to 3.77 million.
Coeptis Therapeutics Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended COEP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) trade information
Instantly COEP has showed a red trend with a performance of -13.65% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3410 on recent trading dayincreased the stock’s daily price by 47.21%. The company’s shares are currently down -76.76% year-to-date, but still up 26.09% over the last five days. On the other hand, Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) is -5.45% down in the 30-day period. We can see from the shorts that 0.15 million shares have been sold at a short interest cover period of 0.4 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -311.69%.
COEP Dividends
Coeptis Therapeutics Holdings Inc’s next quarterly earnings report is expected to be released in January.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 18.53% of Coeptis Therapeutics Holdings Inc shares, and 4.28% of them are in the hands of institutional investors. The stock currently has a share float of 5.25%.
